14 completed, 1 terminated. 9 Phase 3, 3 Phase 4, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 9 |
| Phase 4 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 2 | Completed 2 |
Follow Vistakon Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of a Drug Delivery System in Glaucoma High Dose Drug Device, Low Dose Drug Device, Placebo Device - Open-angle Glaucoma, Ocular Hypertension | Phase 2 | Completed | Vistakon Pharmaceuticals | 47 | 2009-10-01 | 2015-03-06 |
| Safety and Efficacy Study of a Eye Drop for Eye Allergy alcaftadine, Placebo - Allergic Conjunctivitis | Phase 3 | Completed | Vistakon Pharmaceuticals | 60 | 2009-04-01 | 2015-03-06 |
| Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers contact lens with ketotifen, contact lens - Allergic Conjunctivitis | Phase 3 | Completed | Vistakon Pharmaceuticals | 250 | 2009-04-01 | 2015-03-06 |
| A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs timolol hemihydrate, timolol maleate - Open-angle Glaucoma, Ocular Hypertension | Completed | Vistakon Pharmaceuticals | 103 | 2009-01-01 | 2015-03-06 | |
| Safety and Efficacy of a Glaucoma Drug Delivery System High Dose Device, Low Dose Device, Placebo Device - Glaucoma, Open-Angle, Ocular Hypertension | Phase 2 | Completed | Vistakon Pharmaceuticals | 55 | 2008-12-01 | 2015-03-06 |
| Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension Timolol Maleate in Sorbate, Timolol hemihydrate, Timolol maleate gel forming solution - Glaucoma, Open Angle, Ocular Hypertension | Phase 4 | Completed | Vistakon Pharmaceuticals | 30 | 2008-11-01 | 2015-03-06 |
| Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery 1.5% levofloxacin ophthalmic solution, 0.5% moxifloxacin ophthalmic solution - Corneal Transplantation | Phase 4 | Terminated | Santen Inc. | 60 | 2008-09-01 | 2009-08-26 |
| Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator 1.5% levofloxacin ophthalmic solution, 0.5% moxifloxacin hydrochloride ophthalmic solution - Cataract | Phase 4 | Completed | Santen Inc. | 96 | 2008-02-01 | 2009-02-06 |
| Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers K-Lens (generic name not established) and Ketotifen, Placebo Lens - Allergic Conjunctivitis | Phase 3 | Completed | Vistakon Pharmaceuticals | 310 | 2007-10-01 | 2015-03-06 |
| Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis Ketotifen with a Contact Lens (no generic name) - Allergic Conjunctivitis | Phase 3 | Completed | Vistakon Pharmaceuticals | 120 | 2007-02-01 | 2009-04-09 |
| Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis Ketotifen with a Contact Lens (generic name not yet established) - Allergic Conjunctivitis | Phase 3 | Completed | Vistakon Pharmaceuticals | 120 | 2007-01-01 | 2009-04-09 |
| Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis R89674 0.025% ophthalmic solution - Allergic Conjunctivitis | Phase 3 | Completed | Vistakon Pharmaceuticals | 365 | 2006-08-01 | 2011-09-27 |
| Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis R89674 (generic name not yet established) - Allergic Conjunctivitis | Phase 3 | Completed | Vistakon Pharmaceuticals | 150 | 2005-10-01 | 2011-09-27 |
| Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis R89674 (generic name not yet established) - Allergic Conjunctivitis | Phase 3 | Completed | Vistakon Pharmaceuticals | 110 | 2005-10-01 | 2011-09-27 |
| Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers R89674 (generic name not yet established) - Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis | Phase 3 | Completed | Vistakon Pharmaceuticals | 900 | 2005-09-01 | 2015-02-20 |
Conjunctivitis, Allergic (9) · Glaucoma, Open-Angle (4) · Ocular Hypertension (4) · Cataract (1)
Ketotifen (2) · Timolol (2) · Contact Lenses (1) · Moxifloxacin (1) · Ophthalmic Solutions (1) · alcaftadine (1)
United States (15)
Brian Pall, OD, MS, FAAO (4) · Ingerman Avner, MD (2) · William C. Stewart, MD (2) · Jack V Greiner, OD, DO, PhD (1) · Reza Haque, MD (1)